SEC Form 4 · accession 0001104659-16-140757
Amphastar Pharmaceuticals, Inc. · AMPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Diane G. Gerst
Officer — EVP, QA & Regulatory Affairs
Period of report
Aug 19, 2016
Accepted (ET)
Aug 19, 2016 · 7:26 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001297184
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 19, 2016 | M | 10,046 | $14.23 | A | 39,031 | D | |
| Common Stock | Aug 19, 2016 | M | 14,000 | $10.93 | A | 53,031 | D | |
| Common Stock | Aug 19, 2016 | S | 24,046 | $19.28 | D | 28,985 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F2 | $14.23 | Aug 19, 2016 | M | 10,046 | D | — | Dec 22, 2021 | Common Stock | 10,046 | 4,954 | D |
| Employee Stock Option (right to buy)F2 | $10.93 | Aug 19, 2016 | M | 14,000 | D | — | Jul 30, 2023 | Common Stock | 14,000 | 14,000 | D |
Explanation of responses
- F1The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 17, 2016.
- F2Shares subject to the option are fully vested and immediately exercisable.